Analysis of the expression of SMYD2 across BC subclasses showed significant overexpression in luminal (n = 566), HER2+ (n = 37), and TNBC (n = 116) compared to normal breast tissues (n = 114). This evidence concerns the gene SMYD2 and breast cancer.